CoChat
Sign Up
Cited by 366Bipolar Disorder and TreatmentGenetic Associations and EpidemiologySchizophrenia research and treatment

Genome-wide association study of bipolar disorder in European American and African American individuals

Open access
Smith, E N, Bloss, C S, Badner, J A, Barrett, T, Belmonte, P L, Berrettini, W, Byerley, W, Coryell, W +29 more·2009·Molecular Psychiatry
DOI 10.1038/mp.2009.43PMC PMC3035981
Open this paper in CoChat — free account

Abstract

To identify bipolar disorder (BD) genetic susceptibility factors, we conducted two genome-wide association (GWA) studies: one involving a sample of individuals of European ancestry (EA; n=1001 cases; n=1033 controls), and one involving a sample of individuals of African ancestry (AA; n=345 cases; n=670 controls). For the EA sample, single-nucleotide polymorphisms (SNPs) with the strongest statistical evidence for association included rs5907577 in an intergenic region at Xq27.1 (P=1.6 x 10(-6)) and rs10193871 in NAP5 at 2q21.2 (P=9.8 x 10(-6)). For the AA sample, SNPs with the strongest statistical evidence for association included rs2111504 in DPY19L3 at 19q13.11 (P=1.5 x 10(-6)) and rs2769605 in NTRK2 at 9q21.33 (P=4.5 x 10(-5)). We also investigated whether we could provide support for three regions previously associated with BD, and we showed that the ANK3 region replicates in our sample, along with some support for C15Orf53; other evidence implicates BD candidate genes such as SLITRK2. We also tested the hypothesis that BD susceptibility variants exhibit genetic background-dependent effects. SNPs with the strongest statistical evidence for genetic background effects included rs11208285 in ROR1 at 1p31.3 (P=1.4 x 10(-6)), rs4657247 in RGS5 at 1q23.3 (P=4.1 x 10(-6)), and rs7078071 in BTBD16 at 10q26.13 (P=4.5 x 10(-6)). This study is the first to conduct GWA of BD in individuals of AA and suggests that genetic variations that contribute to BD may vary as a function of ancestry.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mp.2009.43

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The enriched pathways were tested in rare CNVs from large independent case-control datasets: 8,290 schizophrenia cases and 7,431 controls from Vacic et al., a combined sample from three studies, and a bipolar disorder case-control set of 2,777 cases and 3,508 controls from BiGS.

    “We extended our analysis of pathways identified in this study (Table 4 and Table 5, and S7) to rare CNVs from large case-controls studies of SCZ and BD. These included rare CNVs from 8,290 SCZ cases and 7,431 controls from Vacic et al. (2011), a combined sample of three studies from our group, MGS (Levinson et al., 2011), and the International Schizophrenia Consortium (International Schizophrenia”

    From High frequencies of de novo CNVs in bipolar disorder and schizophrenia (2011) · cites this paper as Smith et al., 2009

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 51 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Related

Authors
Smith, E. N., Bloss, C. S., Badner, J. A., Barrett, T., Belmonte, P. L., Berrettini, W., Byerley, W., Coryell, W., Craig, D., Edenberg, H. J., Eskin, E., Foroud, T., Gershon, E., Greenwood, T. A., Hipolito, M., Koller, D. L., Lawson, W. B., Liu, C., Lohoff, F., McInnis, M. G., McMahon, F. J., Mirel, D. B., Murray, S. S., Nievergelt, C., Nurnberger, J., Nwulia, E. A., Paschall, J., Potash, J. B., Rice, J., Schulze, T. G., Scheftner, W., Panganiban, C., Zaitlen, N., Zandi, P. P., Zöllner, S., Schork, N. J., & Kelsoe, J. R.
Affiliations
  • Scripps Health (US)
  • University of Chicago (US)
  • Portland VA Medical Center (US)
  • Johns Hopkins University (US)
  • University of Pennsylvania (US)
  • University of California, San Francisco (US)
  • University of Iowa (US)
  • Translational Genomics Research Institute (US)
  • Indiana University Indianapolis (US)
  • University of California, Los Angeles (US)
  • University of California San Diego (US)
  • Howard University (US)
  • Indiana University School of Medicine (US)
  • University of Michigan (US)
  • National Institutes of Health (US)
  • Broad Institute (US)
  • Scripps Research Institute (US)
  • Washington University in St. Louis (US)
  • Rush University (US)
Corresponding author
Schork, N J
ORCID
Venue
Molecular Psychiatry
Publisher
Springer Science and Business Media LLC
Published
2009-06-02
Volume
14
Issue
8
Pages
755-763
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
DOI
10.1038/mp.2009.43
PMC
PMC3035981
OpenAlex
W2136702573
Cited by
363
References
51
Citations by year
2026: 1 · 2025: 10 · 2024: 5 · 2023: 10 · 2022: 8 · 2021: 14 · 2020: 19 · 2019: 15 · 2018: 16 · 2017: 21 · 2016: 17 · 2015: 22 · 2014: 30 · 2013: 37 · 2012: 52
FWCI
27.54
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion)
Funders
  • National Institutes of Health (5u01mh046280-08, 5u01mh046274-08)
  • University of California, San Diego
  • National Heart, Lung, and Blood Institute (K25HL080079)
  • National Institute of Mental Health (R01MH059553, Z01MH002810, MH081804, R01MH078151, R01MH059545, R01MH059534, R01MH059533, U01MH046282, R01MH059567, R01MH059556, MH078151, R01MH059535, R01MH094483, U01 MH 46280, R01MH081804, K01MH072866, R01MH059548, R01MH060068, K08MH080372, MH059567, U01 MH 46274)
  • National Human Genome Research Institute
  • National Center for Research Resources (1U54RR025204-01, UL1RR025774)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
bipolar disorder, genetic susceptibility, single nucleotide polymorphisms, African American ancestry, NTRK2, ANK3, ROR1, RGS5, candidate genes
MeSH terms
Adolescent, Adult, Bipolar Disorder, Black or African American, Female, Haplotypes, Humans, Male, Middle Aged, Reference Values, Cohort Studies, Genome, Human, Case-Control Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, White People, Genome-Wide Association Study, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review